Published in J Pain Symptom Manage on July 16, 2007
Transdermal buprenorphine - a critical appraisal of its role in pain management. J Pain Res (2009) 0.88
Opioids switching with transdermal systems in chronic cancer pain. J Exp Clin Cancer Res (2009) 0.87
Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain. J Pain Res (2014) 0.84
Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review. Ther Clin Risk Manag (2009) 0.77
Equipotent doses to switch from high doses of opioids to transdermal buprenorphine. Support Care Cancer (2008) 0.77
Use of immediate-release opioids as supplemental analgesia during management of moderate-to-severe chronic pain with buprenorphine transdermal system. J Pain Res (2017) 0.75
Physician empathy: definition, components, measurement, and relationship to gender and specialty. Am J Psychiatry (2002) 4.20
An empirical study of decline in empathy in medical school. Med Educ (2004) 3.52
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res (2007) 3.22
Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients: a randomized controlled trial. JAMA (2010) 3.20
Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage (2004) 1.67
Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo. Blood (2003) 1.65
Empathy scores in medical school and ratings of empathic behavior in residency training 3 years later. J Soc Psychol (2005) 1.61
A five-year retrospective study of the epidemiological characteristics and visual outcomes of patients hospitalized for ocular trauma in a Mediterranean area. BMC Ophthalmol (2008) 1.49
Evaluation of esophageal motility using multichannel intraluminal impedance in healthy children and children with gastroesophageal reflux. J Pediatr Gastroenterol Nutr (2011) 1.49
The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen. Curr Med Res Opin (2013) 1.47
Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases. N Z Med J (2003) 1.47
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma. Cancer Treat Rev (2010) 1.45
Efficacy of periportal infiltration and intraperitoneal instillation of ropivacaine after laparoscopic surgery in children. J Laparoendosc Adv Surg Tech A (2009) 1.43
One-year outcomes with new-generation multifocal intraocular lenses. Ophthalmology (2008) 1.35
The stethoscope as metaphor. Cleve Clin J Med (2012) 1.29
Phase II study of sorafenib in patients with sunitinib-refractory metastatic renal cell cancer. J Clin Oncol (2009) 1.27
Relationships between scores of the Jefferson Scale of Physician Empathy (JSPE) and the Interpersonal Reactivity Index (IRI). Med Teach (2005) 1.20
Deep sclerectomy versus punch trabeculectomy with or without phacoemulsification: a randomized clinical trial. J Glaucoma (2004) 1.16
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? Cancer Treat Rev (2010) 1.15
Physical exercise and quality of life in breast cancer survivors. Int J Med Sci (2008) 1.14
Management of painful bone metastases. Curr Opin Oncol (2007) 1.12
Palliative sedation in patients with advanced cancer followed at home: a systematic review. J Pain Symptom Manage (2011) 1.06
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain (2008) 1.04
Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine (2012) 1.04
Sleep disorders in advanced cancer patients: prevalence and factors associated. Support Care Cancer (2004) 1.03
KPC - 3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients. BMC Anesthesiol (2013) 1.03
Weekly administration of paclitaxel: theoretical and clinical basis. Crit Rev Oncol Hematol (2002) 1.01
Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up. Ophthalmologica (2008) 1.01
Surveillance of multidrug-resistant gram-negative bacilli in a neonatal intensive care unit: prominent role of cross transmission. Am J Infect Control (2007) 1.01
Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage (2009) 1.00
Is ranibizumab effective in stopping the loss of vision for choroidal neovascularisation in pathologic myopia? A long-term follow-up study. Br J Ophthalmol (2010) 0.99
Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer (2004) 0.98
Optimization of opioid therapy for preventing incident pain associated with bone metastases. J Pain Symptom Manage (2004) 0.97
Peritoneal catheter for continuous drainage of ascites in advanced cancer patients. Support Care Cancer (2008) 0.97
Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage (2005) 0.96
The use of high doses of oxycodone in an acute palliative care unit. Am J Hosp Palliat Care (2010) 0.96
High-dose furosemide and small-volume hypertonic saline solution infusion for the treatment of leg edema in advanced cancer patients. J Pain Symptom Manage (2008) 0.96
Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. J Pain Symptom Manage (2007) 0.95
Opioid escalation in patients with cancer pain: the effect of age. J Pain Symptom Manage (2006) 0.95
TLR4 upregulation underpins airway neutrophilia in smokers with chronic obstructive pulmonary disease and acute respiratory failure. Hum Immunol (2010) 0.95
Comparisons of nurses and physicians on an operational measure of empathy. Eval Health Prof (2004) 0.95
Octreotide for malignant bowel obstruction: twenty years after. Crit Rev Oncol Hematol (2012) 0.95
Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Clin J Pain (2007) 0.93
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome. Clin Cancer Res (2008) 0.93
Jefferson Scale of Patient's Perceptions of Physician Empathy: preliminary psychometric data. Croat Med J (2007) 0.93
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival. Clin Cancer Res (2006) 0.93
Cryptic Leishmania infantum infection in Italian HIV infected patients. BMC Infect Dis (2009) 0.93
The Supportive Care Task Force at the University of L'Aquila: 2-years experience. Support Care Cancer (2005) 0.92
Enhancing and sustaining empathy in medical students. Med Teach (2013) 0.92
Serum interleukin-6 in patients with metastatic bone disease: correlation with cystatin C. Med Oncol (2008) 0.92
Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF). Clin Sci (Lond) (2009) 0.92
Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience. Clin Neuropharmacol (2010) 0.92
Controlled sedation for refractory symptoms in dying patients. J Pain Symptom Manage (2008) 0.91
The medical oncologist's role in palliative care: AIOM's position. Tumori (2010) 0.91
Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab. Clin Colorectal Cancer (2011) 0.91
Tapentadol in cancer pain management: a prospective open-label study. Curr Med Res Opin (2012) 0.91
In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human breast cancer cells. Bone (2004) 0.91
Can malignant bowel obstruction in advanced cancer patients be treated at home? Support Care Cancer (2010) 0.91
E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial. Acta Ophthalmol (2007) 0.90
Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line. Anticancer Res (2004) 0.90
The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy. Support Care Cancer (2007) 0.90
Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose. J Pain Symptom Manage (2004) 0.90
"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study. BMC Cancer (2010) 0.90
Patients' and relatives' perceptions about intravenous and subcutaneous hydration. J Pain Symptom Manage (2005) 0.89
The long and winding road to useful predictive factors for anti-EGFR therapy in metastatic colorectal carcinoma: the KRAS/BRAF pathway. Oncology (2010) 0.89
Efficacy and safety of deep, continuous palliative sedation at home: a retrospective, single-institution study. Support Care Cancer (2009) 0.89
Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer. J Cancer Res Clin Oncol (2011) 0.88
Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine. J Pain Symptom Manage (2006) 0.87